Growth Metrics

Novartis Ag (NVS) Revenue (QoQ) (2009 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 8,102.16%
Mar 31, 2023 27.56%
Dec 31, 2022 7.63%
Sep 30, 2022 -99.06%
Jun 30, 2022 9,649.03%
Mar 31, 2022 -99.39%
Dec 31, 2021 18,498.23%
Sep 30, 2021 -99.10%
Jun 30, 2021 8,827.40%
Mar 31, 2021 16.12%
Dec 31, 2020 1.68%
Sep 30, 2020 -98.98%
Jun 30, 2020 9,687.03%
Jun 30, 2019 13,331.91%
Mar 31, 2019 3.07%
Dec 31, 2018 -10.59%
Sep 30, 2018 -99.09%
Jun 30, 2018 13,054.72%
Mar 31, 2018 4.95%
Dec 31, 2017 5.21%
Sep 30, 2017 -0.52%
Dec 31, 2016 25,660.43%
Sep 30, 2016 17.61%
Jun 30, 2016 84,126,884.13%
Mar 31, 2016 -100.00%
Dec 31, 2015 44,827,586,206,796.56%
Mar 31, 2015 72.41%
Dec 31, 2014 -6.45%
Jun 30, 2010 -100.00%
Mar 31, 2010 93,849,605,446,287.12%
Dec 31, 2009 -100.00%
Sep 30, 2009 105,120,424,805,613,408.00%
Jun 30, 2009 -99.89%